First patient is randomized in a late-stage anaesthesiology trial

Phase III multi-center double-blind anaesthesiology study outsourced to GCT by a leading Russian pharmaceutical company gets off the ground within the projected timelines.

Following screening procedures and randomization, first subject successfully underwent a complicated abdominal surgery,  with the use of an inhalational anesthesia this Monday.  Patient feels well now, and GCT team was happy to contribute to his fast recovery.

The study is being conducted at two investigative sites in Russia each aiming to enroll 60 subjects within the aggressive timelines.